Table 5.
Intensive treatment* |
Conventional treatment† |
|||||
---|---|---|---|---|---|---|
Pregnancy state | OR | 95% CI | P | OR | 95% CI | P |
Changed to intensive therapy before conception but not yet pregnant‡ |
- | - | - | 1.56 | 0.53–4.56 | NS |
Pregnant vs. not pregnant | 1.37 | 0.56–3.33 | NS | 2.90 | 1.45–5.82 | 0.003 |
First trimester | - | - | - | 1.93 | 0.57–6.61 | NS |
Second trimester | - | - | - | 4.26 | 2.05–8.88 | <0.001 |
Third trimester | - | - | - | 2.56 | 0.91–7.26 | NS |
After pregnancy | ||||||
0–6 months | 1.54 | 0.81–2.95 | NS | 3.16 | 1.61–6.19 | <0.001 |
6–12 months | 1.38 | 0.65–2.90 | NS | 2.87 | 1.37–6.01 | 0.005 |
>12 months | 0.65 | 0.31–1.36 | NS | 1.19 | 0.60–2.40 | NS |
Data are adjusted for time in study, baseline retinopathy status, age, duration of diabetes, screening HbA1c, history of pregnancy, prior # DCCT, and current mean HbA1c.
OR versus not pregnant
OR versus not pregnant and not changed to intensive therapy in preparation for conception
unadjusted for first, second, or third trimester.